This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción MED
Igeamed S.p.A. provides consulting, engineering, training, and medical services.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Igeamed S.p.A.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €2.50 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.12 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 66.67% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| MED | IT Professional Services | Mercado IT | |
|---|---|---|---|
| 7D | 0% | 1.8% | 2.6% |
| 1Y | 0% | 9.4% | 23.7% |
Rentabilidad vs. Industria: MED exceeded the Italian Professional Services industry which returned -19.6% over the past year.
Rentabilidad vs. Mercado: MED underperformed the Italian Market which returned 6.3% over the past year.
Volatilidad de los precios
| MED volatility | |
|---|---|
| MED Average Weekly Movement | 0% |
| Professional Services Industry Average Movement | 3.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in IT Market | 8.1% |
| 10% least volatile stocks in IT Market | 2.8% |
Precio estable de las acciones: MED has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine MED's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1979 | 26 | Michele Casciani | www.igeam.it |
Resumen de fundamentos de Igeamed S.p.A.
| Estadísticas fundamentales de MED | |
|---|---|
| Capitalización bursátil | €5.65m |
| Beneficios(TTM) | -€21.93k |
| Ingresos (TTM) | €7.69m |
0.7x
Ratio precio-ventas (PS)-257.5x
Ratio precio-beneficio (PE)¿Está MED sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MED | |
|---|---|
| Ingresos | €7.69m |
| Coste de los ingresos | €7.12m |
| Beneficio bruto | €572.09k |
| Otros gastos | €594.02k |
| Beneficios | -€21.93k |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.0097 |
| Margen bruto | 7.44% |
| Margen de beneficio neto | -0.29% |
| Ratio deuda/patrimonio | 56.3% |
¿Cómo se ha desempeñado MED a largo plazo?
Ver rendimiento histórico y comparativa